Synagis

Significance There is considerable interest in developing immunosuppressants that can specifically target effector memory T cells… Expand

Intramuscular injections are contra-indicated in infants with either acquired or congenital bleeding disorders. In such patients… Expand

1. A method for isolating Synagisiz composition comprising Synagis, the method comprising: i. carrying out an ion exchange… Expand

The present invention has for its object a method for separating an antibody from a composition. In some embodiments, this method… Expand

Infants receive many painful immunizations before they are 2 years old. The purpose of this study was to evaluate if topical… Expand

 

DESCRIPTION: Synagis® (palivizumab) is a humanized monoclonal antibody (IgG1κ ) produced by recombinant DNA technology, directed… Expand

Palivizumab (Synagis; Abbott Laboratories), a humanized, monoclonal antibody, prevents lower respiratory tract infection by… Expand

Respiratory Syncytial Virus (RSV) can be devastating to premature infants and children with chronic lung disease. Palivizumab… Expand

To the Editor. The continuing reports, letters, and pharmacoeconomic analyses concerning the use of expensive respiratory… Expand